Related references
Note: Only part of the references are listed.Druggability modification strategies of the diarylpyrimidine-type non-nucleoside reverse transcriptase inhibitors
Li Ding et al.
MEDICINAL RESEARCH REVIEWS (2021)
Harnessing noncovalent interaction of chalcogen bond in organocatalysis: From the catalyst point of view
Weitao Yan et al.
GREEN SYNTHESIS AND CATALYSIS (2021)
Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity against K103N and E138K Mutants and Pharmacokinetic Profiles
Sheng Han et al.
ACS INFECTIOUS DISEASES (2020)
Development of non-nucleoside reverse transcriptase inhibitors (NNRTIs): our past twenty years
Chunlin Zhuang et al.
ACTA PHARMACEUTICA SINICA B (2020)
In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development
Israel Agranat et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Asymmetric catalysis in synthetic strategies for chiral benzothiazepines
Haifeng Wang et al.
GREEN SYNTHESIS AND CATALYSIS (2020)
Asymmetric catalytic hydrogenation of imines and enamines in natural product synthesis
Pei Tang et al.
GREEN SYNTHESIS AND CATALYSIS (2020)
Fifty Years in Search of Selective Antiviral Drugs
Erik De Clercq
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Rapid Identification of Keap1-Nrf2 Small-Molecule Inhibitors through Structure-Based Virtual Screening and Hit-Based Substructure Search
Chunlin Zhuang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Diverse combinatorial design, synthesis and in vitro evaluation of new HEPT analogues as potential non-nucleoside HIV-1 reverse transcription inhibitors
Raimon Puig-de-la-Bellacasa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later
Christophe Pannecouque et al.
NATURE PROTOCOLS (2008)
Synthesis and anti-HIV activity evaluation of 1-[alkenyl or alkynyl or alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Lei Ji et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2007)
Nonnucleoside HIV-1 reverse-transcriptase inhibitors, part 5. Synthesis and anti-HIV-1 activity of novel 6-naphthylthio HEPT analogues
GF Sun et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2005)
An efficient preparation of 1-phenylsulfonylindolyl methyl sulfoxides using KF/m-CPBA
AK Mohanakrishnan et al.
TETRAHEDRON LETTERS (2005)
Synthesis of novel N-1 (allyloxymethyl) analogues of 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine) with improved activity against HIV-1 and its mutants
NR El-Brollosy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: Role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors
J Auwerx et al.
MOLECULAR PHARMACOLOGY (2002)
Share Paper
